Kelly James Patrick
Insider CIK 1506314 · NVAX EVP, CFO and Treasurer · VNDA SVP, CFO, Sec & Treasurer · SUPN Executive Vice-President & CFO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NVAX NOVAVAX INC | M Exercise deriv | 2026-03-07 | 2026-03-09 | 12,223 | — | $0 | 0 | SEC↗ |
| NVAX NOVAVAX INC | F Tax w/h | 2026-03-07 | 2026-03-09 | 5,904 | $9.98 | $58.9K | 130,599 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2026-03-07 | 2026-03-09 | 12,223 | — | $0 | 136,503 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2026-03-03 | 2026-03-05 | 43,167 | — | $0 | 86,333 | SEC↗ |
| NVAX NOVAVAX INC | F Tax w/h | 2026-03-03 | 2026-03-05 | 20,850 | $9.49 | $197.9K | 124,280 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2026-03-03 | 2026-03-05 | 43,167 | — | $0 | 145,130 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2026-03-02 | 2026-03-03 | 129,500 | — | $0 | 129,500 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2026-03-02 | 2026-03-03 | 194,000 | $9.09 | $1.76M | 194,000 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2026-03-02 | 2026-03-09 | 194,000 | — | $0 | 194,000 | SEC↗ |
| NVAX NOVAVAX INC | D To issuer deriv | 2026-03-01 | 2026-03-03 | 58,666 | — | $0 | 58,666 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2026-03-01 | 2026-03-03 | 58,666 | — | $0 | 130,299 | SEC↗ |
| NVAX NOVAVAX INC | F Tax w/h | 2026-03-01 | 2026-03-03 | 28,366 | $10.14 | $287.6K | 101,963 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2025-03-07 | 2025-03-11 | 12,223 | — | $0 | 12,223 | SEC↗ |
| NVAX NOVAVAX INC | F Tax w/h | 2025-03-07 | 2025-03-11 | 5,904 | $8.34 | $49.2K | 69,251 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2025-03-07 | 2025-03-11 | 12,223 | — | $0 | 75,155 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2025-03-03 | 2025-03-05 | 194,500 | $7.87 | $1.53M | 194,500 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2025-03-03 | 2025-03-05 | 129,500 | — | $0 | 129,500 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2025-03-01 | 2025-03-04 | 58,667 | — | $0 | 117,333 | SEC↗ |
| NVAX NOVAVAX INC | F Tax w/h | 2025-03-01 | 2025-03-04 | 28,337 | $8.33 | $236.0K | 62,932 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2025-03-01 | 2025-03-04 | 58,667 | — | $0 | 91,269 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2024-12-31 | 2025-01-03 | 35,000 | — | $0 | 0 | SEC↗ |
| NVAX NOVAVAX INC | F Tax w/h | 2024-12-31 | 2025-01-03 | 16,906 | $8.04 | $135.9K | 32,602 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2024-12-31 | 2025-01-03 | 35,000 | — | $0 | 49,508 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2024-08-16 | 2024-08-20 | 2,367 | — | $0 | 0 | SEC↗ |
| NVAX NOVAVAX INC | F Tax w/h | 2024-08-16 | 2024-08-20 | 1,223 | $12.96 | $15.9K | 14,429 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2024-08-16 | 2024-08-20 | 2,367 | $12.96 | $30.7K | 15,652 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2024-03-10 | 2024-03-12 | 4,608 | — | $0 | 4,608 | SEC↗ |
| NVAX NOVAVAX INC | F Tax w/h | 2024-03-10 | 2024-03-12 | 2,226 | $5.45 | $12.1K | 13,285 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2024-03-10 | 2024-03-12 | 4,608 | — | $0 | 15,511 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2024-03-07 | 2024-03-11 | 12,224 | — | $0 | 24,446 | SEC↗ |
| NVAX NOVAVAX INC | F Tax w/h | 2024-03-07 | 2024-03-11 | 5,905 | $5.61 | $33.1K | 10,903 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2024-03-07 | 2024-03-11 | 12,224 | — | $0 | 16,808 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2024-03-01 | 2024-03-26 | 176,000 | — | $0 | 176,000 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2023-09-12 | 2024-03-11 | 35,000 | — | $0 | 35,000 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2023-08-16 | 2023-08-18 | 2,366 | — | $0 | 2,367 | SEC↗ |
| NVAX NOVAVAX INC | F Tax w/h | 2023-08-16 | 2023-08-18 | 1,143 | $7.13 | $8.1K | 4,584 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2023-08-16 | 2023-08-18 | 2,366 | — | $0 | 5,727 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2023-03-10 | 2023-03-14 | 4,609 | — | $0 | 9,216 | SEC↗ |
| NVAX NOVAVAX INC | F Tax w/h | 2023-03-10 | 2023-03-14 | 2,471 | $6.52 | $16.1K | 3,361 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2023-03-10 | 2023-03-14 | 4,609 | $6.52 | $30.1K | 5,832 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2023-03-07 | 2023-03-09 | 36,670 | — | $0 | 36,670 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2023-03-07 | 2023-03-09 | 42,350 | — | $0 | 42,350 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2022-08-16 | 2022-08-18 | 2,367 | — | $0 | 4,733 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2022-08-16 | 2022-08-18 | 2,367 | — | $0 | 2,367 | SEC↗ |
| NVAX NOVAVAX INC | F Tax w/h | 2022-08-16 | 2022-08-18 | 1,144 | $42.88 | $49.1K | 1,223 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2022-03-10 | 2022-03-14 | 20,737 | — | $0 | 20,737 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2022-03-10 | 2022-03-14 | 13,825 | — | $0 | 13,825 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2021-08-16 | 2021-08-18 | 7,100 | — | $0 | 7,100 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2021-08-16 | 2021-08-18 | 14,200 | — | $0 | 14,200 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2021-02-19 | 2021-02-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2020-10-12 | 2020-10-13 | 135,000 | — | $0 | 135,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | S Sale | 2020-03-03 | 2020-03-04 | 5,889 | $10.76 | $63.4K | 186,869 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | S Sale | 2020-03-02 | 2020-03-04 | 12,968 | $10.19 | $132.1K | 192,758 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | S Sale | 2020-01-02 | 2020-01-06 | 4,020 | $15.94 | $64.1K | 205,726 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | S Sale | 2019-03-04 | 2019-03-04 | 8,751 | $19.88 | $174.0K | 209,746 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | S Sale | 2019-03-01 | 2019-03-04 | 4,976 | $20.15 | $100.3K | 218,497 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2019-02-27 | 2019-03-01 | 70,000 | — | $0 | 70,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award | 2019-02-27 | 2019-03-01 | 30,000 | — | $0 | 223,473 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | S Sale | 2019-01-03 | 2019-01-04 | 1,619 | $26.09 | $42.2K | 193,473 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | S Sale | 2019-01-02 | 2019-01-04 | 1,129 | $26.94 | $30.4K | 195,092 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | S Sale | 2019-01-02 | 2019-01-04 | 3,313 | $26.31 | $87.2K | 196,221 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | S Sale | 2018-03-01 | 2018-03-02 | 8,532 | $18.72 | $159.7K | 199,534 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2018-02-28 | 2018-03-02 | 80,000 | — | $0 | 80,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award | 2018-02-28 | 2018-03-02 | 40,000 | — | $0 | 208,066 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise deriv | 2018-01-02 | 2018-01-04 | 5,000 | — | $0 | 5,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise deriv | 2018-01-02 | 2018-01-04 | 5,000 | — | $0 | 0 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise deriv | 2018-01-02 | 2018-01-04 | 7,500 | — | $0 | 15,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise | 2018-01-02 | 2018-01-04 | 5,000 | — | $0 | 144,721 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | S Sale | 2018-01-02 | 2018-01-04 | 9,155 | $15.35 | $140.5K | 168,066 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise | 2018-01-02 | 2018-01-04 | 5,000 | — | $0 | 154,721 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise | 2018-01-02 | 2018-01-04 | 7,500 | — | $0 | 177,221 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2017-03-01 | 2017-03-03 | 70,000 | — | $0 | 70,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award | 2017-03-01 | 2017-03-03 | 70,000 | — | $0 | 139,721 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise deriv | 2017-01-03 | 2017-01-05 | 5,000 | — | $0 | 10,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise deriv | 2017-01-03 | 2017-01-05 | 5,000 | — | $0 | 5,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise deriv | 2017-01-03 | 2017-01-05 | 2,344 | — | $0 | 0 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise deriv | 2017-01-03 | 2017-01-05 | 7,500 | — | $0 | 22,500 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | S Sale | 2017-01-03 | 2017-01-05 | 10,895 | $15.51 | $169.0K | 69,721 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise | 2017-01-03 | 2017-01-05 | 2,344 | — | $0 | 63,116 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise | 2017-01-03 | 2017-01-05 | 7,500 | — | $0 | 80,616 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise | 2017-01-03 | 2017-01-05 | 5,000 | — | $0 | 73,116 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise | 2017-01-03 | 2017-01-05 | 5,000 | — | $0 | 68,116 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2016-02-12 | 2016-02-17 | 70,000 | — | $0 | 70,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2016-02-12 | 2016-02-17 | 30,000 | — | $0 | 30,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise deriv | 2016-01-04 | 2016-01-06 | 5,000 | — | $0 | 15,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise deriv | 2016-01-04 | 2016-01-06 | 5,000 | — | $0 | 10,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise deriv | 2016-01-04 | 2016-01-06 | 2,344 | — | $0 | 2,344 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise deriv | 2016-01-04 | 2016-01-06 | 4,688 | — | $0 | 0 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise | 2016-01-04 | 2016-01-06 | 5,000 | — | $0 | 65,336 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise | 2016-01-04 | 2016-01-06 | 5,000 | — | $0 | 70,336 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | S Sale | 2016-01-04 | 2016-01-06 | 9,564 | $8.96 | $85.7K | 60,772 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise | 2016-01-04 | 2016-01-06 | 2,344 | — | $0 | 60,336 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise | 2016-01-04 | 2016-01-06 | 4,688 | — | $0 | 57,992 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise deriv | 2015-03-10 | 2015-03-12 | 4,687 | — | $0 | 4,688 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise deriv | 2015-03-10 | 2015-03-12 | 12,500 | — | $0 | 0 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise deriv | 2015-03-10 | 2015-03-12 | 5,000 | — | $0 | 15,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise deriv | 2015-03-10 | 2015-03-12 | 2,344 | — | $0 | 4,688 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | S Sale | 2015-03-10 | 2015-03-12 | 12,450 | $10.53 | $131.1K | 53,304 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise | 2015-03-10 | 2015-03-12 | 5,000 | — | $0 | 65,754 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise | 2015-03-10 | 2015-03-12 | 2,344 | — | $0 | 60,754 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise | 2015-03-10 | 2015-03-12 | 4,687 | — | $0 | 58,410 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise | 2015-03-10 | 2015-03-12 | 12,500 | — | $0 | 53,723 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2014-12-04 | 2014-12-05 | 20,000 | — | $0 | 20,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2014-12-04 | 2014-12-05 | 60,000 | — | $0 | 60,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise deriv | 2014-02-18 | 2014-02-20 | 2,343 | — | $0 | 7,032 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise deriv | 2014-02-18 | 2014-02-20 | 4,688 | — | $0 | 9,375 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise deriv | 2014-02-18 | 2014-02-20 | 12,500 | — | $0 | 12,500 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise | 2014-02-18 | 2014-02-20 | 2,343 | — | $0 | 48,347 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | F Tax w/h | 2014-02-18 | 2014-02-20 | 7,124 | $13.46 | $95.9K | 41,223 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise | 2014-02-18 | 2014-02-20 | 4,688 | — | $0 | 46,004 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise | 2014-02-18 | 2014-02-20 | 12,500 | — | $0 | 41,316 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2013-12-02 | 2013-12-04 | 20,000 | — | $0 | 20,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2013-12-02 | 2013-12-04 | 60,000 | — | $0 | 60,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | S Sale | 2013-11-19 | 2013-11-21 | 3,348 | $12.07 | $40.4K | 28,816 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise deriv | 2013-07-29 | 2013-07-31 | 9,375 | — | $0 | 9,375 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise | 2013-07-29 | 2013-07-31 | 9,375 | — | $0 | 32,164 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise deriv | 2013-02-14 | 2013-02-19 | 12,500 | — | $0 | 25,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise deriv | 2013-02-14 | 2013-02-19 | 4,687 | — | $0 | 14,063 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise | 2013-02-14 | 2013-02-19 | 12,500 | — | $0 | 25,080 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise | 2013-02-14 | 2013-02-19 | 4,687 | — | $0 | 29,767 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | F Tax w/h | 2013-02-14 | 2013-02-19 | 6,978 | $3.95 | $27.6K | 22,789 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2012-12-07 | 2012-12-11 | 56,250 | — | $0 | 56,250 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2012-12-07 | 2012-12-11 | 18,750 | — | $0 | 18,750 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise deriv | 2012-02-16 | 2012-02-21 | 12,500 | — | $0 | 37,500 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise | 2012-02-16 | 2012-02-21 | 12,500 | — | $0 | 17,500 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | S Sale | 2012-02-16 | 2012-02-21 | 4,920 | $4.67 | $23.0K | 12,580 | SEC↗ |